Pillar1ClinicalTrials - Pillar-1 Participation

For U.S. residents only.

Non-U.S. residents

Learn About Novartis

Learn About Clinical Trials

Who can participate in the Pillar-1 study?

All clinical studies have guidelines about who can participate. This study is open to adult patients (at least 18 years of age) with mantle cell lymphoma whose condition has been documented to be resistant to previous treatment.

There are also other more specific requirements called inclusion/exclusion criteria that your doctor can review with you if you are interested in taking part in the study. If you satisfy all of these requirements, you may be eligible to participate in this study.

What are the advantages and disadvantages of being a participant in the PILLAR-1 clinical study?

Advantages

Play an active role in your own health care
Gain access to new research treatments before they are widely available
Obtain expert medical care at leading health care facilities during the study
Help others by contributing to medical research

Disadvantages
You may experience unpleasant, serious, or even life-threatening side effects
The study treatment may not be effective for you
The protocol may require more of your time and attention than you anticipate, including trips to the study site, more treatments, or dosage requirements

What is the time commitment?

Participants will be required to visit the study doctor twice per month during the first 3 months and, then every 28 days until treatment with the study drug is finished.

How do I find out if I qualify?

To find out if you qualify, take our screening questionnaire. If you qualify for this trial, you will then be asked to select a medical site within your selected mileage radius. The medical facility you select will then contact you to set up a formal screening appointment to determine if this trial is right for you.

What is the cost to participate?

The study medication will be provided to you at no cost.

To see if you qualify for this important Novartis research study, click on the link below.

To view all Novartis clinical trials recruiting in the U.S., visit NovartisClinicalTrials.com